Studies have demonstrated that allopurinol can significantly improve endothelial function in patients with CKD or chronic heart failure [47] and xanthine oxidase inhibitor reduce the incidence of adverse CV events [48]. This evidence concerns the gene XDH and chronic kidney disease.